Radiofrequency catheter ablation of supraventricular tachycardia in infants and toddlers

Circ J. 2009 Sep;73(9):1717-21. doi: 10.1253/circj.cj-09-0123. Epub 2009 Jul 17.

Abstract

Background: The role of radiofrequency catheter ablation (RFCA) of supraventricular tachycardia (SVT) in infants and toddlers is still unclear.

Methods and results: From 1993 to 2006, 27 (17 males, 10 females) of 210 patients underwent RFCA at an age less than 6 years. Indications included drug-refractory SVT or tachycardia-induced cardiomyopathy. The medical records were reviewed and the patients were interviewed regarding their current status. The 27 patients underwent RFCA at a median age of 4.4 years (8 months to 5.9 years) and a median body weight of 15 kg (6.6-30 kg). The SVT was mainly atrioventricular reentry tachycardia (15/27) and multiple mechanisms in 3. One-third of them had associated congenital heart disease, and 5 underwent RFCA using only 2-3 catheters. Immediate success rate was 92.6%, with low early (3.7%) and late recurrence (7.4%) after 5.4 +/-3.7 years follow-up. Tachycardia-induced cardiomyopathy was noted in 4 and resolved in all after RFCA. Procedure-related complications included complete atrioventricular block in 1 and Bezold-Jarisch reflex in another. No other risk factors for outcomes were noted, even with low body weight.

Conclusions: The outcome of RFCA for medically refractory SVT, even associated with tachycardia-induced cardiomyopathy, in infants and toddlers is favorable.

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Atrioventricular Block / etiology
  • Body Weight
  • Cardiomyopathies / etiology
  • Cardiomyopathies / surgery
  • Catheter Ablation* / adverse effects
  • Child
  • Child, Preschool
  • Drug Resistance
  • Electrophysiologic Techniques, Cardiac
  • Female
  • Humans
  • Infant
  • Male
  • Recurrence
  • Reflex
  • Risk Assessment
  • Tachycardia, Atrioventricular Nodal Reentry / complications
  • Tachycardia, Atrioventricular Nodal Reentry / physiopathology
  • Tachycardia, Atrioventricular Nodal Reentry / surgery*
  • Tachycardia, Supraventricular / complications
  • Tachycardia, Supraventricular / physiopathology
  • Tachycardia, Supraventricular / surgery*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents